Cabergoline, also known as Dostinex, is a dopaminergic medication used to treat high prolactin levels, prolactinomas, Parkinson’s disease, and other conditions. It is taken orally.
Cabergoline is a dopamine D2 receptor agonist and an ergot derivative.
Cabergoline was approved for medical use in 1993 after being patented in 1980.
There are no reviews yet.